Consistent with our previous report, a numbered of well-defined SCC oncogenes had super-enhancers, (e.g. TP63, SOX2, EGFR, and MYC)13,20–22,25 in four ESCC cell lines. This evidence concerns the gene MYC and esophageal squamous cell carcinoma.